Predictive values of systemic inflammation biomarkers in proliferative vitreoretinopathy associated with primary rhegmatogenous retinal detachment

References

• Sadaka A, Giuliari GP. Proliferative vitreoretinopathy: current and emerging treatments. Clin Ophthalmol 2012; 6: 1325–1333.
   PubMedGoogle Scholar
• Pennock S, Haddock LJ, Eliott D, et al. Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy? Prog Retin Eye Res 2014; 40: 16–34.
   PubMed Web of Science ®Google Scholar
• Pastor JC, Rojas J, Pastor-Idoate S, et al. Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res 2016; 51: 125–155.
   PubMed Web of Science ®Google Scholar
• Mudhar HS. A brief review of the histopathology of proliferative vitreoretinopathy (PVR). Eye (Lond) 2020; 34: 246–250.
   PubMed Web of Science ®Google Scholar
• Kon CH, Asaria RH, Occleston NL, et al. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol 2000; 84: 506–511.
   PubMed Web of Science ®Google Scholar
• Johnsen EO, Frøen RC, Albert R, et al. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy. Exp Eye Res 2012; 98: 28–36.
   PubMed Web of Science ®Google Scholar
• Oberstein SY, Byun J, Herrera D, et al. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Mol Vis 2011; 17: 1794–1805.
   PubMed Web of Science ®Google Scholar
• Ricker LJ, Kijlstra A, Kessels AG, et al. Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study. PLoS One 2011; 6: e19141.
   PubMed Web of Science ®Google Scholar
• Symeonidis C, Papakonstantinou E, Androudi S, et al. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade. Cytokine 2014; 67: 71–76.
   PubMed Web of Science ®Google Scholar
• Kon CH, Occleston NL, Aylward GW, et al. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci 1999; 40: 705–712.
   PubMed Web of Science ®Google Scholar
• Robbins SG, Mixon RN, Wilson DJ, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994; 35: 3649–3663.
   PubMed Web of Science ®Google Scholar
• Ni Y, Qin Y, Huang Z, et al. Distinct serum and vitreous inflammation-related factor profiles in patients with proliferative vitreoretinopathy. Adv Ther 2020; 37: 2550–2559.
   PubMed Web of Science ®Google Scholar
• Ichsan AM, Windy DA, Muhiddin HS, et al. Comparison between vascular endothelial growth factor and platelet-derived growth factor levels in rhegmatogenous retinal detachment. J Ophthalmol 2021; 2021: 2688837.
   PubMed Web of Science ®Google Scholar
• Feng F, Tian Y, Liu S, et al. Combination of PLR, MLR, MWR, and tumor size could significantly increase the prognostic value for gastrointestinal stromal tumors. Med (Baltimore) 2016; 95: e3248.
   PubMed Web of Science ®Google Scholar
• Serfőző G, Horváth T, Földesi I, et al. The monocyte-to-lymphocyte ratio correlates with psycho-neuro-inflammatory factors in patients with stable coronary artery disease. Neuroimmunomodul 2016; 23: 67–74.
   PubMed Web of Science ®Google Scholar
• Fest J, Ruiter R, Mulder M, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-a population-based cohort study. Int J Cancer 2020; 146: 692–698.
   PubMed Web of Science ®Google Scholar
• Pinna A, Porcu T, D’Amico-Ricci G, et al. Complete blood cell count-derived inflammation biomarkers in men with age-related macular degeneration. Ocul Immunol Inflamm 2019; 27: 932–936.
   PubMed Web of Science ®Google Scholar
• Bozkurt E, Ucak T. Serum inflammation biomarkers in patients with keratoconus. Ocul Immunol Inflamm 2021 Aug 18; 29 (6): 1164–1167.
   PubMed Web of Science ®Google Scholar
• Celik T. Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with dry eye disease. Ocul Immunol Inflamm 2018; 26: 1219–1222.
   PubMed Web of Science ®Google Scholar
• Elbeyli A, Kurtul BE, Ozcan SC, et al. The diagnostic value of systemic immune-inflammation index in diabetic macular oedema. Clin Exp Optom 2021: 1–5.
   PubMed Web of Science ®Google Scholar
• Zhang A, Ning L, Han J, et al. Neutrophil-to-lymphocyte ratio as a potential biomarker of neovascular glaucoma. Ocul Immunol Inflamm 2021; 29: 417–424.
   PubMed Web of Science ®Google Scholar
• Machemer R, Aaberg TM, Freeman HM, et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1991; 112: 159–165.
   PubMed Web of Science ®Google Scholar
• Pan M, Zhou P, Liu Z, et al. Peripheral complete blood cell count indices and serum lipid levels in polypoidal choroidal vasculopathy. Clin Exp Optom 2022: 1–6.
   Web of Science ®Google Scholar
• Koçak N, Eraydın B, Turunç M, et al. Serum inflammatory biomarkers in patients with nonarteritic anterior ischemic optic neuropathy. Korean J Ophthalmol 2020; 34: 478–484.
   PubMedGoogle Scholar
• Chaudhary R, Scott RAH, Wallace G, et al. Inflammatory and fibrogenic factors in proliferative vitreoretinopathy development. Transl Vis Sci Technol 2020; 9: 23.
   PubMed Web of Science ®Google Scholar
• Moysidis SN, Thanos A, Vavvas DG. Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. Mediators Inflamm 2012; 2012: 815937.
   PubMed Web of Science ®Google Scholar
• Okunuki Y, Mukai R, Pearsall EA, et al. Microglia inhibit photoreceptor cell death and regulate immune cell infiltration in response to retinal detachment. Proc Natl Acad Sci U S A 2018; 115: E6264–e6273.
   PubMed Web of Science ®Google Scholar
• Wang X, Miller EB, Goswami M, et al. Rapid monocyte infiltration following retinal detachment is dependent on non-canonical IL6 signaling through gp130. J Neuroinflammat 2017; 14: 121.
   PubMed Web of Science ®Google Scholar
• Andrews A, Balciunaite E, Leong FL, et al. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1999; 40: 2683–2689.
   PubMed Web of Science ®Google Scholar
• Hinton DR, He S, Jin ML, et al. Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye (Lond) 2002; 16: 422–428.
   PubMed Web of Science ®Google Scholar
• Ricker LJ, Dieudonné SC, Kessels AG, et al. Antiangiogenic isoforms of vascular endothelial growth factor predominate in subretinal fluid of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Retina 2012; 32: 54–59.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Savant V, Scott RA, et al. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci 2007; 48: 2203–2207.
   PubMed Web of Science ®Google Scholar
• Yu J, Peng R, Chen H, et al. Kininogen 1 and insulin-like growth factor binding protein 6: candidate serum biomarkers of proliferative vitreoretinopathy. Clin Exp Optom 2014; 97: 72–79.
   PubMed Web of Science ®Google Scholar
• Bozkurt E, Ucak T. Serum inflammation biomarkers in patients with keratoconus. Ocul Immunol Inflamm 2021; 29: 1164–1167.
   PubMed Web of Science ®Google Scholar
• Ilhan N, Daglioglu MC, Ilhan O, et al. Assessment of neutrophil/lymphocyte ratio in patients with age-related macular degeneration. Ocul Immunol Inflamm 2015; 23: 287–290.
   PubMed Web of Science ®Google Scholar
• Katipoğlu Z, Mirza E, Oltulu R, et al. May monocyte/HDL cholesterol ratio (MHR) and neutrophil/lymphocyte ratio (NLR) be an indicator of inflammation and oxidative stress in patients with keratoconus? Ocul Immunol Inflamm 2020; 28: 632–636.
   PubMed Web of Science ®Google Scholar
• Tang B, Li S, Han J, et al. Associations between blood cell profiles and primary open-angle glaucoma: a retrospective case-control study. Ophthalmic Res 2020; 63: 413–422.
   PubMed Web of Science ®Google Scholar
• Sertoglu E, Uyanik M. Accurate use of neutrophil/lymphocyte ratio from the perspective of laboratory experts. Vasc Health Risk Manag 2014; 10: 13–14.
   PubMedGoogle Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nat 2002; 420: 860–867.
   Google Scholar
• Ozarslan Ozcan D, Kurtul BE, Ozcan SC, et al. Increased systemic immune-inflammation index levels in patients with dry eye disease. Ocul Immunol Inflamm 2022 Apr 3; 30 (3): 588–592.
   PubMed Web of Science ®Google Scholar
• Guven S, Kilic D. Neutrophil to lymphocyte ratio (NLR) is a better tool rather than monocyte to high-density lipoprotein ratio (MHR) and platelet to lymphocyte ratio (PLR) in central retinal artery occlusions. Ocul Immunol Inflamm 2021; 29: 997–1001.
   PubMed Web of Science ®Google Scholar